VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NTLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NTLAIntellia Therapeutics, Inc.
$16.61$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNTLAQuarterly Financials

Intellia Therapeutics, Inc. (NTLA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Intellia Therapeutics, Inc. (NTLA) quarterly income statement — complete revenue, gross profit & net income history

NTLA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue15.05M23.02M13.78M14.24M16.63M12.87M9.11M6.96M28.93M-1.92M11.99M13.59M12.61M13.57M13.27M14.03M11.25M12.85M7.2M6.55M
Revenue Growth %-9.5%78.79%51.27%104.76%-42.54%771.57%-24.02%-48.82%129.53%-114.12%-9.6%-3.11%12.03%5.59%84.15%114.2%74.58%94.91%-67.58%-59.72%
Cost of Goods Sold2.2M6.01M78.95M00002.6M2.51M2.47M2.29M115.28M97.12M100.03M96.65M90.2M133.09M71.16M60.49M58.88M
COGS % of Revenue14.63%26.13%572.84%----37.36%8.68%-128.64%19.1%847.99%770.39%737.01%728.56%642.9%1182.86%553.61%839.62%898.99%
Gross Profit12.85M17M-65.17M14.24M16.63M12.87M9.11M4.36M26.42M-4.38M9.7M-101.68M-84.51M-86.46M-83.39M-76.17M-121.84M-58.31M-53.28M-52.33M
Gross Margin %85.37%73.87%-472.84%100%100%100%100%62.64%91.32%228.64%80.9%-747.99%-670.39%-637.01%-628.56%-542.9%-1082.86%-453.61%-739.62%-798.99%
Gross Profit Growth %-22.74%32.06%-815.26%226.87%-37.07%393.73%-6.09%104.29%131.27%94.93%111.64%-33.5%30.64%-48.29%-56.5%-45.54%-271.12%-84.31%-203.84%-143.32%
Operating Expenses113.38M115.71M46.31M124.24M137.43M149.32M153.88M143.4M140.43M135.51M140.81M30.65M27.45M23.63M22.14M22.13M22.4M22.11M18.71M16.68M
OpEx % of Revenue753.44%502.72%336.02%872.17%826.57%1159.86%1688.96%2061.25%485.32%-7068.81%1174.19%225.48%217.74%174.07%166.93%157.75%199.1%171.99%259.73%254.7%
Selling, General & Admin34.84M33.08M46.31M27.21M29.01M32.44M30.5M31.79M31.09M28.99M29.4M30.65M27.45M23.63M22.14M22.13M22.4M22.11M18.71M16.68M
SG&A % of Revenue231.55%143.7%336.02%190.99%174.46%252.01%334.77%456.99%107.45%-1512.47%245.19%225.48%217.74%174.07%166.93%157.75%199.1%171.99%259.73%254.7%
Research & Development80.74M88.65M94.75M97.03M108.43M116.88M123.38M111.61M109.33M108.98M113.7M115.28M97.12M100.03M96.65M90.2M133.09M71.16M60.49M58.88M
R&D % of Revenue536.53%385.16%687.47%681.19%652.11%907.85%1354.19%1604.25%377.86%-5684.98%948.1%847.99%770.39%737.01%728.56%642.9%1182.86%553.61%839.62%898.99%
Other Operating Expenses-1000K-1000K-1000K000000-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-100.53M-98.71M-111.48M-110M-120.81M-136.45M-144.77M-139.04M-114M-139.89M-131.11M-132.33M-111.96M-110.09M-105.53M-98.3M-144.25M-80.42M-71.99M-69.02M
Operating Margin %-668.08%-428.86%-808.86%-772.17%-726.57%-1059.86%-1588.96%-1998.61%-394%7297.44%-1093.29%-973.47%-888.13%-811.07%-795.49%-700.65%-1281.96%-625.6%-999.35%-1053.69%
Operating Income Growth %16.78%27.66%23%20.89%-5.97%2.46%-10.42%-5.07%-1.83%-27.07%-24.24%-34.62%22.38%-36.9%-46.58%-42.43%-210.71%-89.66%-156.18%-108.93%
EBITDA-98.33M-98.33M-106.54M-107.52M-118.31M-133.88M-142.16M-136.44M-111.49M-137.43M-128.82M-130.16M-109.91M-108.06M-103.58M-96.46M-142.49M-78.53M-70.21M-67.38M
EBITDA Margin %-653.44%-427.22%-773.04%-754.81%-711.55%-1039.93%-1560.33%-1961.25%-385.32%7168.81%-1074.19%-957.51%-871.87%-796.11%-780.79%-687.56%-1266.37%-610.98%-974.56%-1028.75%
EBITDA Growth %16.89%26.55%25.06%21.2%-6.12%2.58%-10.36%-4.82%-1.44%-27.18%-24.36%-34.94%22.87%-37.59%-47.54%-43.16%-217.82%-92.5%-164.93%-114.13%
D&A (Non-Cash Add-back)2.2M377K4.94M2.47M2.5M2.57M2.61M2.6M2.51M2.47M2.29M2.17M2.05M2.03M1.95M1.84M1.75M1.88M1.79M1.63M
EBIT-100.53M-95.79M-101.32M-110M-120.81M-136.45M-144.77M-139.04M-114M-139.89M-131.11M-132.33M-111.96M-110.09M-105.53M-98.3M-144.25M-80.42M-71.99M-69.02M
Net Interest Income5.21M6.48M6.71M7.4M8.6M10.63M12.12M12.42M12.63M12.46M12.74M12.65M11.98M5.35M1.95M703K540K503K349K211K
Interest Income5.21M6.48M6.71M7.4M8.6M10.63M12.12M12.42M12.63M12.46M12.74M12.65M11.98M5.35M1.95M703K540K503K349K211K
Interest Expense00000000000000000000
Other Income/Expense4.3M2.92M10.15M8.74M6.48M7.55M9.06M-7.93M6.57M7.73M8.88M8.65M8.83M-3.32M-7.7M-2.38M-2.63M-822K349K211K
Pretax Income-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M-71.64M-68.81M
Pretax Margin %-639.49%-416.15%-735.19%-710.81%-687.61%-1001.23%-1489.54%-2112.62%-371.3%6894.16%-1019.21%-909.82%-818.07%-835.53%-853.53%-717.59%-1305.3%-632%-994.5%-1050.47%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M-71.64M-68.81M
Net Margin %-639.49%-416.15%-735.19%-710.81%-687.61%-1001.23%-1489.54%-2112.62%-371.3%6894.16%-1019.21%-909.82%-818.07%-835.53%-853.53%-717.59%-1305.3%-632%-994.5%-1050.47%
Net Income Growth %15.83%25.69%25.34%31.11%-6.42%2.47%-11.04%-18.83%-4.18%-16.54%-7.94%-22.85%29.79%-39.6%-58.04%-46.32%-217.87%-92.54%-157.34%-112.41%
Net Income (Continuing)-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M-71.64M-68.81M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.81-0.83-0.92-0.98-1.10-1.27-1.34-1.52-1.12-1.46-1.38-1.40-1.17-1.40-1.49-1.33-1.96-1.09-0.97-1.01
EPS Growth %26.36%34.65%31.34%35.53%1.79%13.01%2.9%-8.38%4.27%-4.57%7.31%-5.63%40.45%-27.92%-53.49%-31.47%-184.75%-58.19%-106.38%-65.57%
EPS (Basic)-0.81-0.83-0.92-0.98-1.10-1.27-1.34-1.52-1.12-1.46-1.38-1.40-1.17-1.40-1.49-1.33-1.96-1.09-0.97-1.01
Diluted Shares Outstanding118.49M108.38M110.19M103.73M103.5M101.86M101M96.97M95.5M90.46M88.64M88.19M87.77M81.22M76.05M75.82M74.75M74.43M73.71M68.16M
Basic Shares Outstanding118.49M108.38M110.19M103.73M103.5M101.86M101M96.97M95.5M90.46M88.64M88.19M87.77M81.22M76.05M75.82M74.75M74.43M73.71M68.16M
Dividend Payout Ratio--------------------